• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Evolutionary dynamics of tumor progression with random fitness values.具有随机适应度值的肿瘤进展的进化动力学
Theor Popul Biol. 2010 Aug;78(1):54-66. doi: 10.1016/j.tpb.2010.05.001. Epub 2010 May 19.
2
Diploidy and the selective advantage for sexual reproduction in unicellular organisms.二倍体与单细胞生物有性生殖的选择优势。
Theory Biosci. 2009 Nov;128(4):249-85. doi: 10.1007/s12064-009-0077-9. Epub 2009 Nov 10.
3
Stochastic dynamics of cancer initiation.癌症发生的随机动力学。
Phys Biol. 2011 Feb;8(1):015002. doi: 10.1088/1478-3975/8/1/015002. Epub 2011 Feb 7.
4
Evolutionary triage governs fitness in driver and passenger mutations and suggests targeting never mutations.进化筛选决定了驱动突变和乘客突变中的适应性,并建议针对非必需突变。
Nat Commun. 2014 Nov 19;5:5499. doi: 10.1038/ncomms6499.
5
Mutations, evolution and the central role of a self-defined fitness function in the initiation and progression of cancer.突变、进化以及自我定义的适合度函数在癌症发生和进展中的核心作用。
Biochim Biophys Acta Rev Cancer. 2017 Apr;1867(2):162-166. doi: 10.1016/j.bbcan.2017.03.005. Epub 2017 Mar 21.
6
Every which way? On predicting tumor evolution using cancer progression models.条条大路通罗马?基于肿瘤进展模型预测肿瘤演化。
PLoS Comput Biol. 2019 Aug 2;15(8):e1007246. doi: 10.1371/journal.pcbi.1007246. eCollection 2019 Aug.
7
Inferring the distribution of fitness effects of spontaneous mutations in Chlamydomonas reinhardtii.推断莱茵衣藻自发突变的适应性效应分布。
PLoS Biol. 2019 Jun 26;17(6):e3000192. doi: 10.1371/journal.pbio.3000192. eCollection 2019 Jun.
8
A stochastic version of the Price equation reveals the interplay of deterministic and stochastic processes in evolution.普赖斯方程的一个随机版本揭示了进化过程中确定性过程与随机过程的相互作用。
BMC Evol Biol. 2008 Sep 25;8:262. doi: 10.1186/1471-2148-8-262.
9
Tug-of-war between driver and passenger mutations in cancer and other adaptive processes.癌症及其他适应性过程中驱动突变与乘客突变之间的较量。
Proc Natl Acad Sci U S A. 2014 Oct 21;111(42):15138-43. doi: 10.1073/pnas.1404341111. Epub 2014 Oct 2.
10
Epigenetic mutations can both help and hinder adaptive evolution.表观遗传突变既能促进也能阻碍适应性进化。
Mol Ecol. 2016 Apr;25(8):1856-68. doi: 10.1111/mec.13296. Epub 2015 Jul 30.

引用本文的文献

1
Direct inference of the distribution of fitness effects of spontaneous mutations from recombinant inbred Caenorhabditis elegans mutation accumulation lines.直接推断自发突变的适合度效应分布从重组近交系 Caenorhabditis elegans 突变积累系。
Genetics. 2024 Oct 7;228(2). doi: 10.1093/genetics/iyae136.
2
A seven-step guide to spatial, agent-based modelling of tumour evolution.肿瘤演化的基于主体的空间建模七步指南。
Evol Appl. 2024 May 2;17(5):e13687. doi: 10.1111/eva.13687. eCollection 2024 May.
3
The network structure affects the fixation probability when it couples to the birth-death dynamics in finite population.网络结构会影响与有限群体中的生死动力学耦合时的固定概率。
PLoS Comput Biol. 2021 Oct 27;17(10):e1009537. doi: 10.1371/journal.pcbi.1009537. eCollection 2021 Oct.
4
Signatures of neutral evolution in exponentially growing tumors: A theoretical perspective.指数增长肿瘤中中性进化的特征:理论视角。
PLoS Comput Biol. 2021 Feb 11;17(2):e1008701. doi: 10.1371/journal.pcbi.1008701. eCollection 2021 Feb.
5
Universal scaling laws rule explosive growth in human cancers.通用标度律支配着人类癌症的爆发式生长。
Nat Phys. 2020 Dec;16(12):1232-1237. doi: 10.1038/s41567-020-0978-6. Epub 2020 Aug 10.
6
Cancer recurrence times from a branching process model.从分支过程模型看癌症复发次数。
PLoS Comput Biol. 2019 Nov 21;15(11):e1007423. doi: 10.1371/journal.pcbi.1007423. eCollection 2019 Nov.
7
Cooperative adaptation to therapy (CAT) confers resistance in heterogeneous non-small cell lung cancer.协同治疗适应(CAT)赋予异质性非小细胞肺癌的耐药性。
PLoS Comput Biol. 2019 Aug 26;15(8):e1007278. doi: 10.1371/journal.pcbi.1007278. eCollection 2019 Aug.
8
Phenotypic heterogeneity in modeling cancer evolution.癌症进化建模中的表型异质性。
PLoS One. 2017 Oct 30;12(10):e0187000. doi: 10.1371/journal.pone.0187000. eCollection 2017.
9
Non-cell-autonomous effects yield lower clonal diversity in expanding tumors.非细胞自主效应导致扩张肿瘤中的克隆多样性降低。
Sci Rep. 2017 Sep 11;7(1):11157. doi: 10.1038/s41598-017-11562-w.
10
Genotype by random environmental interactions gives an advantage to non-favored minor alleles.基因型与随机环境相互作用赋予非优势次要等位基因优势。
Sci Rep. 2017 Jul 12;7(1):5193. doi: 10.1038/s41598-017-05375-0.

本文引用的文献

1
MOLECULAR EVOLUTION OVER THE MUTATIONAL LANDSCAPE.突变景观上的分子进化
Evolution. 1984 Sep;38(5):1116-1129. doi: 10.1111/j.1558-5646.1984.tb00380.x.
2
Evolution of resistance and progression to disease during clonal expansion of cancer.癌症克隆扩增过程中耐药性的演变与疾病进展
Theor Popul Biol. 2010 Feb;77(1):42-8. doi: 10.1016/j.tpb.2009.10.008. Epub 2009 Nov 5.
3
Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution.在单核苷酸分辨率下分析的小叶型乳腺肿瘤中的突变进化。
Nature. 2009 Oct 8;461(7265):809-13. doi: 10.1038/nature08489.
4
Beneficial fitness effects are not exponential for two viruses.有益的健康效应对于两种病毒而言并非呈指数关系。
J Mol Evol. 2008 Oct;67(4):368-76. doi: 10.1007/s00239-008-9153-x. Epub 2008 Sep 9.
5
Variability and robustness in T cell activation from regulated heterogeneity in protein levels.蛋白质水平调控异质性导致的T细胞激活中的变异性和稳健性。
Science. 2008 Aug 22;321(5892):1081-4. doi: 10.1126/science.1158013.
6
The evolution of two mutations during clonal expansion.克隆扩增过程中两个突变的演变。
Genetics. 2007 Dec;177(4):2209-21. doi: 10.1534/genetics.107.078915.
7
Genetic progression and the waiting time to cancer.基因进展与患癌等待时间。
PLoS Comput Biol. 2007 Nov;3(11):e225. doi: 10.1371/journal.pcbi.0030225.
8
Testing the extreme value domain of attraction for distributions of beneficial fitness effects.测试有益适合度效应分布的极值吸引域。
Genetics. 2007 Aug;176(4):2441-9. doi: 10.1534/genetics.106.068585. Epub 2007 Jun 11.
9
Can loss of apoptosis protect against cancer?细胞凋亡的缺失能预防癌症吗?
Trends Genet. 2007 May;23(5):232-7. doi: 10.1016/j.tig.2007.03.005. Epub 2007 Mar 26.
10
Evolution of resistance during clonal expansion.克隆扩增过程中耐药性的演变。
Genetics. 2006 Apr;172(4):2557-66. doi: 10.1534/genetics.105.049791.

具有随机适应度值的肿瘤进展的进化动力学

Evolutionary dynamics of tumor progression with random fitness values.

作者信息

Durrett Rick, Foo Jasmine, Leder Kevin, Mayberry John, Michor Franziska

机构信息

Department of Mathematics, Cornell University, Ithaca, NY 14853, United States.

出版信息

Theor Popul Biol. 2010 Aug;78(1):54-66. doi: 10.1016/j.tpb.2010.05.001. Epub 2010 May 19.

DOI:10.1016/j.tpb.2010.05.001
PMID:20488197
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2929987/
Abstract

Most human tumors result from the accumulation of multiple genetic and epigenetic alterations in a single cell. Mutations that confer a fitness advantage to the cell are known as driver mutations and are causally related to tumorigenesis. Other mutations, however, do not change the phenotype of the cell or even decrease cellular fitness. While much experimental effort is being devoted to the identification of the functional effects of individual mutations, mathematical modeling of tumor progression generally considers constant fitness increments as mutations are accumulated. In this paper we study a mathematical model of tumor progression with random fitness increments. We analyze a multi-type branching process in which cells accumulate mutations whose fitness effects are chosen from a distribution. We determine the effect of the fitness distribution on the growth kinetics of the tumor. This work contributes to a quantitative understanding of the accumulation of mutations leading to cancer.

摘要

大多数人类肿瘤源于单个细胞中多种基因和表观遗传改变的积累。赋予细胞适应性优势的突变被称为驱动突变,与肿瘤发生存在因果关系。然而,其他突变并不会改变细胞的表型,甚至会降低细胞适应性。虽然目前有大量实验致力于确定单个突变的功能效应,但肿瘤进展的数学模型通常认为随着突变的积累,适应性会持续增加。在本文中,我们研究了具有随机适应性增加的肿瘤进展数学模型。我们分析了一个多类型分支过程,其中细胞积累的突变其适应性效应是从一个分布中选取的。我们确定了适应性分布对肿瘤生长动力学的影响。这项工作有助于对导致癌症的突变积累进行定量理解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4b0/2929987/49cf318e4709/nihms212822f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4b0/2929987/6e59453094b5/nihms212822f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4b0/2929987/49cf318e4709/nihms212822f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4b0/2929987/6e59453094b5/nihms212822f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e4b0/2929987/49cf318e4709/nihms212822f2.jpg